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Edited by Gerrit van MeerAbstract Previously, it was shown that the recruitment of RET
into lipid rafts by glial cell line-derived neurotrophic factor
(GDNF)/GFRa1 is crucial for eﬃcient signal transduction.
Here, we show that the mouse GFRa4 is a functional, N-
glycosylated, glycosylphosphatidylinositol (GPI)-anchored pro-
tein, which mediates persephin (PSPN)-induced phosphorylation
of RET, but has an almost undetectable capacity to recruit RET
into the 0.1% Triton X-100 insoluble membrane fraction. In spite
of this, PSPN/mGFRa4 promotes neurite outgrowth in PC6-3
cells and survival of cerebellar granule neurons. As we show that
also human PSPN/GFRa4 is unable to recruit RET into lipid
rafts, we propose that the mammalian GFRa4 in this respect
diﬀers from GFRa1.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The glial cell line-derived neurotrophic factor (GDNF),
neurturin (NRTN), artemin (ARTN) and persephin (PSPN)
are GDNF family ligands (GFLs) involved in the diﬀerentia-
tion, development, and survival of neurons. These structurally
related neurotrophic factors can support the survival of do-
pamine neurons and motoneurons, and are thus potential
therapeutic agents for neurodegenerative diseases [1]. Each of
these neurotrophic factors preferentially binds to one of the
glycosylphosphatidylinositol (GPI)-anchored GDNF family
receptors a (GFRa). GDNF binds to GFRa1, NRTN to
GFRa2, ARTN to GFRa3 and PSPN to GFRa4. The GFL-
activated GFRa receptors all signal through the receptor ty-
rosine kinase RET [1]. In the presence of GDNF, GFRa1
recruits RET into lipid rafts. The recruitment of RET into
lipid rafts has previously been shown to be required for* Corresponding author. Fax: +358-9-191-59366.
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doi:10.1016/j.febslet.2004.06.007downstream signalling, diﬀerentiation and neuronal survival
[2–4].
The chicken GFRa4 was the ﬁrst identiﬁed receptor for
PSPN [5,6]. Later GFRa4 receptors were characterised in
human [7], rat [8] and mouse [9]. PSPN does not cross-activate
RET through GFRa1 and GDNF does not cross-activate
RET through GFRa4 [7,8]. The mammalian GFRa4 receptors
all lack the ﬁrst N-terminal Cys-rich domain, have short C-
terminal hinge regions and thereby diﬀer in structure from the
other GFRa receptors, including the chicken GFRa4. In spite
of this structural diﬀerence, the human GPI-anchored GFRa4
promotes PSPN-dependent survival of sympathetic neurons
when co-microinjected with RET [7].
The structure and expression of the mouse Gfra4 (mGfra4)
have been characterised [9], but the functionality of this re-
ceptor has not been studied. Here, we characterise the basic
biochemical and cell-biological features of this receptor, and
show that PSPN/GFRa4 contrary to the previously described
GDNF/GFRa1 fails to recruit RET to lipid rafts upon ligand
stimulation.2. Materials and methods
2.1. Constructs, transfections and cell lines
The cDNAs encoding mouse Gfra4-FLAG with an N-terminal
FLAG-tag and rat Gfra1 were cloned into pcDNA3. The cDNAs en-
coding human short isoform of RET (in pBabePuro) and human long
isoform of RET (in pCR3.1) were gifts from Marc Billaud. Neuro 2a
cells (ATCC) were transfected with FuGene 6 (Roche Molecular
Biochemicals), PC6-3 cells [10] with Lipofectamine 2000 (Invitrogen),
and rat primary cerebellar granule neurons with the calcium phosphate
method [11]. The stable Neuro 2a cell line expressing rat Gfra1 was a
gift from Marc Billaud and the Neuro 2a cell line expressing human
GFRA4 has been described by Lindahl et al. [7]. The Neuro 2a cell line
stably expressing mouse Gfra4-FLAG was generated under G418
selection.
2.2. Antibodies
In this work, we used antibodies to FLAG (M2, Sigma, 1:1500),
GFRa1 (WProSci, 1:500), RET (Santa Cruz Biotechnology Inc., C-19
or C-20, 1:500), phosphotyrosine (4G10, Upstate Biotechnology,
1:1500), and transferrin receptor (Zymed Laboratories Inc., 1:500).
2.3. Glycosylation assay
Stably transfected Neuro 2a cells were cultured with tunicamycin
(Sigma) at 5 lg/ml for 16 h. The cells were lysed on ice in lysis buﬀer
(TBS, pH 7.5, 0.2 mM EDTA, 1% Nonidet P-40, 1% Triton X-100,ation of European Biochemical Societies.
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Roche). The post nuclear supernatant (PNS) was analysed by Western
blotting with antibodies to FLAG.
2.4. Membrane association assays
Stably transfected Neuro 2a cells were homogenised in 20 mM
HEPES, pH 7.5, 0.25 mM sucrose, 1 mM EDTA, 1 mM PMSF, and
complete Mini EDTA-free protease inhibitor cocktail, with a syringe.
The PNS was mixed with 67% sucrose to give a ﬁnal concentration of
60% sucrose. The sample was centrifuged in a gradient of 0.5 ml of
67%, 0.5 ml of 60%, 8.0 ml of 50% and 1.0 ml of 5% sucrose (Beckman
SW41 rotor; 35 000 rpm; 8 h; +4 C). Fractions of 0.5 ml were collected
from the top and analysed by Western blotting with antibodies to
FLAG. The phosphatidylinositol-speciﬁc phospholipase C (PI-PLC)
treatments were performed with 1 U/ml of PI-PLC (Sigma), for 40 min,
in PBS, at 37 C. Biotinylation of cell surface proteins with Sulfo-
NHS-Biotin (Pierce) was done according to the manufacturer’s
instructions.
2.5. Binding and crosslinking assays
Human PSPN (PeproTech EC Ltd) was 125I-labelled with the lac-
toperoxidase method and the binding assay as well as crosslinking
assay were performed on transiently and stably transfected Neuro 2a
cells as described earlier [7].
2.6. Phosphorylation assay of RET
Stably transfected Neuro 2a cells were starved for 4 h in serum-free
DMEM at +37 C and then stimulated with 0–100 ng/ml PSPN for 10
min at +37 C. Parental Neuro 2a cells were stimulated with 0–100 ng/
ml GDNF or PSPN (PeproTech EC Ltd.). RET-associated immuno-
complexes were collected with Protein G Sepharose (Amersham
Pharmacia Biotech) beads and analysed by Western blotting with
antibodies to phosphotyrosine and RET.
2.7. Neuronal survival and neurite outgrowth assays
Cerebellar granule neurons (CGNs) were isolated from postnatal
day 7 (P7) rats [12]. On day 5, the cultured neurons were transfected
using the calcium phosphate method. After transfection (24 h), the
neurons were transferred to serum-free low potassium medium (5 mM)
in the presence or absence of PSPN (100 ng/ml). The number of res-
cued neurons was counted 2.5 days later. As one control, the number
of rescued cells was compared to the number of viable cells maintained
in high potassium medium (25 mM). As another control, the cells were
transfected with Gfra1 and RET and supported by GDNF (100 ng/ml)Fig. 1. Characterisation of the FLAG-tagged mouse GFRa4 receptor
(A) Western blot analysis of stably transfected Neuro 2a cells. The
lysate from naive Neuro 2a cells is shown in lane 1. The FLAG-tagged
mGFRa4 is detected with molecular weights of 31 and 33 kD (lane 3)
In the presence of tunicamycin, only the 31 kD band of mGFRa4 is
detectable (lane 2). (B) Membrane association of the mGFRa4
Membranes from Neuro 2a cells expressing GFRa4 were ﬂoated on a
sucrose gradient. The fractions were collected and numbered from the
top, separated on SDS–PAGE and analysed by Western blot with
antibodies to FLAG. (C) Characterisation of the GPI-anchor of the
mGFRa4. Western blot analysis of the cell lysates (lanes 1–2) and
media (lanes 3–4) from Neuro 2a cells stably expressing the mGFRa4
receptor, before (lanes 1 and 3) or after (lanes 2 and 4) PI-PLC
treatment. (D) Biotinylation of cell surface proteins of Neuro 2a cells
stably transfected with Gfra4. As a control, an extract from cells ex
pressing GFRa4 was precipitated with streptavidin, without any pre
ceeding biotinylation (lane 1). An extract of biotinylated cells
expressing the mGFRa4 is shown in lane 2. (E) Crosslinking o
125I-PSPN to Neuro 2a cells transiently transfected with either mGfra4-
FLAG or human GFRA4. After crosslinking, RET was immunopre-
cipitated from the cell extracts, the precipitate was run on a
SDS–PAGE and visualised by autoradiography. (F) Dose-dependent
phosphorylation of RET in Neuro 2a cells stably transfected with
mGFRa4. RET was immunoprecipitated from the cell extracts, and its
phosphorylation was monitored on Western blots with antibodies to
phosphotyrosine, the blot was reprobed with antibodies to RET. (G)
Dose-dependent phosphorylation of RET induced by GDNF in naive
Neuro 2a cells. The assay was done as above, except for the induction
which was done with GDNF..
.
.
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J. Yang et al. / FEBS Letters 569 (2004) 267–271 269in 5 mM potassium. Neurite outgrowth was monitored in transiently
transfected PC6-3 cells, 4–5 days after the addition of GDNF or PSPN
(100 ng/ml).
2.8. Localisation of RET and mGFRa receptors to lipid rafts
Stably transfected Neuro 2a cells were stimulated with GDNF or
PSPN (100 ng/ml) as described for the phosphorylation assay. The cells
were collected into cold isotonic lysis buﬀer and homogenised with a
syringe. After addition of 0.1% Triton X-100 to the PNS, the samples
were kept on ice for 20 min and analysed on OptiPrep density gradi-
ents (0.9 ml 35%, 4.0 ml 30%, and 0.2 ml 0%) as described by Tansey
et al. [2]. Fractions of 0.5 ml were collected from the top and analysed
by Western blotting.Fig. 2. Density gradient analysis of detergent insoluble membrane
fractions. Neuro 2a extracts were analysed in the presence of 0.1%
Triton X-100. Parental Neuro 2a cells are marked as untransfected.
The transfected construct, the addition of ligand and the antibodies
used for Western blotting to detect the GFRa1 receptor, RET, FLAG
or transferrin receptor (TFR), are indicated on the right. Nine frac-
tions from each gradient are shown. The Triton X-100 insoluble top
fraction is shown on the left as the fraction number 1.3. Results
3.1. The mouse GFRa4 is a functional PSPN receptor
Sequence analysis of a putative GFRa4 receptor from
mouse predicted a protein of 260 amino acids, harbouring a
hydrophobic ER signal sequence, one glycosylation site and a
C-terminal GPI-anchor sequence [9]. The predicted molecular
weight of this putative mouse PSPN receptor is 29 kD. Our
Western blot analysis of Neuro 2a cells, stably transfected with
FLAG-tagged mGfra4, shows the tagged protein with molec-
ular weights of 31 and 33 kD, respectively. Tunicamycin
treatment of the cells shows that the 31 kD band is a non-
glycosylated precursor of the glycosylated, mature 33 kD
FLAG-tagged mGFRa4 (Fig. 1A).
To study the membrane association of the putative
mGFRa4, the cell lysate was analysed on a sucrose gradient,
where membranes and proteins bound to the membranes be-
come located in the top fraction. Western blot analysis of the
fractions shows that the FLAG-tagged mGFRa4 is located
in the top fractions (Fig. 1B). PI-PLC treatment of stably
transfected Neuro 2a cells expressing the FLAG-tagged
mGfra4 released the mouse GFRa4 protein from the cell sur-
face and we therefore conclude that the glycosylated 33 kD
mGFRa4 is located on the cell surface, where it is bound to the
membrane by a functional GPI-anchor (Fig. 1C) The cell
surface localisation was further veriﬁed by biotinylation of cell
surface proteins (Fig. 1D).
To determine whether this putative mouse PSPN receptor
directly interacts with PSPN and RET, we used 125I-PSPN and
Neuro 2a cells that endogenously express RET and were
transfected with mGFRa4. The binding of 125I-PSPN to these
cells could be speciﬁcally blocked with unlabelled PSPN, and
the Kd was 2 nM (data not shown). Crosslinking of cell surface
proteins to 125I-PSPN and immunoprecipitation with anti-
bodies to RET revealed two major radioactive bands, which
could be displaced with unlabelled PSPN. The molecular
weight of these bands could correspond to GFRa4-PSPN and
GFRa4-PSPN-RET complexes, respectively (Fig. 1E and
Supplementary Fig. 1).
To study if the mGFRa4 receptor mediates signalling via
RET, we monitored the phosphorylation of RET in Neuro 2a
cells transfected with mGfra4 and stimulated with PSPN. After
immunoprecipitation of the samples with antibodies to RET
and staining of the ﬁlters with antibodies to phosphotyrosine,
we detected a clear dose-dependent phosphorylation of RET
(Fig. 1F). PSPN does not mediate phosphorylation of RET in
untransfected Neuro 2a cells (Supplementary Fig. 2). GDNF
on the other hand mediates a clear and distinct phosphoryla-
tion of RET in untransfected Neuro 2a cells, directlypurchased from the ATCC (Fig. 1G). The presence of an en-
dogenous GFRa1 receptor and the absence of an endogenous
GFRa4 receptor in these cells was veriﬁed by PCR (data not
shown).
3.2. The GFRa4 receptor recruits RET to rafts very weakly
To set up the ﬂotation assay, we used the previously char-
acterised transferrin receptor, GFRa1, and RET as markers
[2]. The transferrin receptor (TFR) was used as a marker for
Triton X-100 soluble fractions, whereas GPI-anchored GFRa1
was used as a marker for Triton X-100 insoluble fractions
(Fig. 2). Although GDNF/GFRa1 induced a clear re-locali-
sation of RET into the insoluble fraction, PSPN/GFRa4 very
weakly recruited RET into this fraction (Fig. 2). As the result
was completely unexpected, we included the following con-
trols. First, we veriﬁed the PSPN-dependent phosphorylation
of RET by splitting the samples and using the other half of
them for phosphorylation assays (Fig. 1F, and Supplementary
Fig. 3). Second, we conﬁrmed that the addition of the ligands
Fig. 3. Density gradient analysis of detergent insoluble membrane
fractions. Neuro 2a cell extracts were analysed in the presence of 0.1 %
Triton X-100. The transfected construct, the addition of ligand and the
antibodies used for Western blotting are indicated on the right. Nine
fractions from each gradient are shown. The Triton X-100 insoluble
top fraction, is shown on the left as the fraction number 1. The ﬁgure
shows that the localisation of GFRa1 is unaﬀected by GDNF and that
the localisation of GFRa4 is unaﬀected by the presence of PSPN.
Fig. 4. Neuronal survival and neurite outgrowth assays. (A) Cell sur-
vival assay with cerebellar granule neurons transiently transfected with
diﬀerent combinations of RET, mGfra4, and rGfra1. PSPN- or
GDNF-dependent cell survival was monitored on transfer to low po-
tassium medium (K5-S). The experiment was repeated three times with
parallel samples. An original ﬁeld of at least 200 transfected cells was
used for each sample. The standard errors are indicated with bars. (B)
PSPN-dependent neurite outgrowth in PC6-3 cells transiently trans-
fected with RET and mGfra4. (C) PSPN and GDNF dependent neurite
outgrowth assay with PC6-3 cells transiently transfected with diﬀerent
combinations of RET, mGfra4, and rGfra1. The experiment was re-
peated three times with parallel samples. A ﬁeld of 200 cells was used
for each sample. The standard errors are indicated with bars.
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GFRa4 receptors in the gradient (Fig. 3). Third, as the amount
of the GFRa1 and the GFRa4 receptors cannot directly be
compared with two diﬀerent antibodies, we instead ensured
that the levels of phosphorylated RET were comparable in the
samples (Supplementary Fig. 3). Fourth, we conﬁrmed that the
N-terminally located FLAG-tag of the mouse GFRa4 receptor
did not disturb the protein interactions, by including a Neuro
2a cell line expressing the non-tagged human GFRa4 as a
control (Fig. 2). This receptor has previously been shown to be
GPI-anchored and to support survival in sympathetic neurons
in the presence of PSPN [7]. As the human un-tagged GFRa4
recruited RET to the top fraction as weakly as the mouse
FLAG-tagged GFRa4, we conclude that the weak recruitment
of RET was not caused by the FLAG-tag.
3.3. The GFRa4 receptor supports cell survival and mediates
neurite outgrowth
The capacity of mGFRa4 to mediate neuronal survival was
tested in rat CGNs. In low potassium (5 mM) and serum-free
medium, CGNs undergo apoptosis [13]. We tested if PSPN
under these conditions could prevent apoptosis of CGNs
transfected with RET and mGFRa4. Both transfected and
untransfected CGNs were viable after 24 h in the medium
containing high (25 mM) potassium concentration and serum
(K25+S). In the presence of 5 mM potassium and serum-free
medium (K5-S), only about 5% of the mock transfected cells
survived. PSPN (100 ng/ml) supported neuronal survival only
in CGNs that were transfected with both mGFRa4-FLAG and
RET, where it increased the percentage of cell survival to 50%
(Fig. 4A).
Previously, it has been reported that PSPN does not have
neurite-promoting eﬀects on mature motor neurons [14], but
increases neurite outgrowth from oculomotor neurons [15].
Here, we tested the neurite outgrowth inducing capacity of the
J. Yang et al. / FEBS Letters 569 (2004) 267–271 271mGFRa4 receptor in transiently transfected PC6-3 cells, which
endogenously express RET at a very low level (data not
shown). After co-transfection with Gfra1/RET or Gfra4/RET,
respectively, both GDNF and PSPN induced a clear network
of neurites (Fig. 4B and C).4. Discussion
Here, we show that PSPN/GFRa4 recruits RET to the raft
fraction very weakly although PSPN/GFRa4 can stimulate
both neurite outgrowth and neuronal survival. Previously, it
was suggested that the recruitment of RET into lipid rafts by
GDNF/GFRa1 is required for downstream signalling, diﬀer-
entiation and neuronal survival [2].
An artiﬁcial transmembrane GFRa1 (GFRa1-TM) was
earlier characterised in Neuro 2a cells where it was shown to
mediate a strong GDNF-induced phosphorylation of RET,
but was located outside the raft fraction. In spite of its full
capacity to mediate the phosphorylation of RET, this trans-
membrane receptor mediated only attenuated neuronal dif-
ferentiation and survival [2]. However, as we show here that
Neuro 2a cells endogenously express GFRa1, which mediates
the phosphorylation of RET in untransfected cells, it is evident
that the functionality of the GFRa1-TM would need further
examinations. The importance of the recruitment of RET into
lipid rafts was also previously studied with the aid of a com-
mercially available soluble GFRa1 [4]. The biological activity
of this receptor is routinely tested by the manufacturer by
assaying its ability to mediate GDNF-induced neurite out-
growth in PC12 cells. Interestingly, the GDNF-activated sol-
uble GFRa1 receptor was inducing a less robust recruitment of
RET to lipid rafts than the GDNF-activated GPI-anchored
GFRa1 receptor [4].
The GPI-anchored mouse GFRa4 receptor is for some
reason not as tightly associated with the raft fraction as the
GPI-anchored GFRa1. Because comparing results with dif-
ferent detergents in diﬀerent cell lines was shown to be diﬃcult
[16], we used the same conditions to show that the localisation
of the two diﬀerent GFRa receptors, as well as their capacity
to re-localise RET in the Triton X-100 soluble/insoluble frac-
tions diﬀer. The localisation of proteins in diﬀerent fractions
has been proposed to depend not only on protein–lipid inter-
actions, but also on protein–protein interactions [17]. As the
structure of the mammalian GFRa4 signiﬁcantly diﬀers from
GFRa1, we propose that GFRa1 and GFRa4 interact diﬀer-
ently with cell surface proteins. Thus, it is possible that our
results with the two GPI-anchored GFRa receptors reﬂect
their diﬀerential interaction with other cell surface proteins.
With the similar method which we used here, phosphory-
lated RET has been detected both outside and inside the raft
fraction after GDNF/GRFa1 stimulation [4]. Therefore, it isevident that we in our work with GFRa4 could not use the
localisation of phosphorylated RET as an indication of whe-
ther PSPN/GFRa4 activates RET inside or outside the rafts.
Moreover, the general signiﬁcance of the content of diﬀerent
detergent insoluble membrane fractions has recently been very
thoroughly questioned [18]. In light of our results, it is at least
clear that a robust recruitment of RET to the lipid rafts cannot
always and tightly be correlated with the biological activity of
a GFRa receptor.
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